156 related articles for article (PubMed ID: 27385215)
1. CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells.
Zaborsky N; Gassner FJ; Asslaber D; Reinthaler P; Denk U; Flenady S; Hofbauer JP; Danner B; Rebhandl S; Harrer A; Geisberger R; Greil R; Egle A
Oncotarget; 2016 Aug; 7(31):49459-49469. PubMed ID: 27385215
[TBL] [Abstract][Full Text] [Related]
2. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
Chen YT; Kung JT
J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
[TBL] [Abstract][Full Text] [Related]
3. Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5(+) B cell expansion.
Palmer VL; Nganga VK; Rothermund ME; Perry GA; Swanson PC
BMC Immunol; 2015 Nov; 16():66. PubMed ID: 26537916
[TBL] [Abstract][Full Text] [Related]
4. Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis.
Gorini F; Azzimonti L; Delfanti G; Scarfò L; Scielzo C; Bertilaccio MT; Ranghetti P; Gulino A; Doglioni C; Di Napoli A; Capri M; Franceschi C; Caligaris-Cappio F; Ghia P; Bellone M; Dellabona P; Casorati G; de Lalla C
Blood; 2017 Jun; 129(26):3440-3451. PubMed ID: 28465341
[TBL] [Abstract][Full Text] [Related]
5. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
Gerth E; Mattner J
Front Immunol; 2019; 10():1449. PubMed ID: 31293596
[TBL] [Abstract][Full Text] [Related]
6. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8
Ghnewa YG; O'Reilly VP; Vandenberghe E; Browne PV; McElligott AM; Doherty DG
Clin Immunol; 2017 Oct; 183():91-98. PubMed ID: 28780376
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets.
Stremmel C; Exley M; Balk S; Hohenberger W; Kuchroo VK
Eur J Immunol; 2001 Sep; 31(9):2818-28. PubMed ID: 11536181
[TBL] [Abstract][Full Text] [Related]
9. Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemia.
Jadidi-Niaragh F; Jeddi-Tehrani M; Ansaripour B; Razavi SM; Sharifian RA; Shokri F
Med Oncol; 2012 Dec; 29(5):3561-9. PubMed ID: 22669567
[TBL] [Abstract][Full Text] [Related]
10. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
Sköld M; Faizunnessa NN; Wang CR; Cardell S
J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
[TBL] [Abstract][Full Text] [Related]
11. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
12. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
[TBL] [Abstract][Full Text] [Related]
13. Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1+ effector memory phenotype.
Göthert JR; Eisele L; Klein-Hitpass L; Weber S; Zesewitz ML; Sellmann L; Röth A; Pircher H; Dührsen U; Dürig J
Cancer Immunol Immunother; 2013 Nov; 62(11):1697-1709. PubMed ID: 24022692
[TBL] [Abstract][Full Text] [Related]
14. CD1d-restricted NKT cells: an interstrain comparison.
Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
[TBL] [Abstract][Full Text] [Related]
15. NKT Cells in Mice Originate from Cytoplasmic CD3-Positive, CD4
Hu Z; Gu W; Wei Y; Liu G; Wu S; Liu T
Sci Rep; 2019 Feb; 9(1):1874. PubMed ID: 30755654
[TBL] [Abstract][Full Text] [Related]
16. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
17. CD1d expression as a prognostic marker for chronic lymphocytic leukemia.
Anastasiadis A; Kotsianidis I; Papadopoulos V; Spanoudakis E; Margaritis D; Christoforidou A; Gouliamtzi S; Tsatalas C
Leuk Lymphoma; 2014 Feb; 55(2):320-5. PubMed ID: 23668820
[TBL] [Abstract][Full Text] [Related]
18. Disruption of a CD1d-mediated interaction between mast cells and NKT cells aggravates atherosclerosis.
Kritikou E; van Duijn J; Nahon JE; van der Heijden T; Bouwman M; Groeneveldt C; Schaftenaar FH; Kröner MJ; Kuiper J; van Puijvelde GHM; Bot I
Atherosclerosis; 2019 Jan; 280():132-139. PubMed ID: 30513408
[TBL] [Abstract][Full Text] [Related]
19. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
[TBL] [Abstract][Full Text] [Related]
20. A Bispecific Single-Domain Antibody Boosts Autologous Vγ9Vδ2-T Cell Responses Toward CD1d in Chronic Lymphocytic Leukemia.
de Weerdt I; Lameris R; Ruben JM; de Boer R; Kloosterman J; King LA; Levin MD; Parren PWHI; de Gruijl TD; Kater AP; van der Vliet HJ
Clin Cancer Res; 2021 Mar; 27(6):1744-1755. PubMed ID: 33451981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
